FDA Gains Cures Funding In Latest Draft
This article was originally published in The Pink Sheet Daily
Executive Summary
Additional appropriations would be authorized for drug development tool qualification and manufacturing studies.
You may also be interested in...
Congressional ‘Cures’ Debate Shifts To FDA Funding
House Democrats say FDA will need more money to be able to handle the responsibilities in the draft bill, while the agency worries reviews could slow without more resources.
GMP Carrots For Quality: FDA Considers Incentives To Adopt Quality Systems
The type of incentive remains under consideration, but one suggestion is a grading system similar to what restaurants receive from local health departments.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.